The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Heggie Theresa since 2019.
This trader's CIK number is 1760020.
At the time of last reporting, Heggie Theresa was the Director of Biocryst Pharmaceuticals Inc. (stock ticker symbol BCRX).
Also see all insider trading activities at Biocryst Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BCRX | 0 | $0 | 70,000 | $595,840 | 70,000 | $291,200 |
| 2019 | BCRX | 5,000 | $7,250 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | BCRX | Sale | 70,000 | 8.51 | 595,840 |
| 2025-08-13 | BCRX | Option Ex | 70,000 | 4.16 | 291,200 |
| 2019-11-18 | BCRX | Buy | 5,000 | 1.45 | 7,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Heggie Theresa (Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.